T1	AdverseReaction 58 69	Neutropenia
T2	AdverseReaction 170 191	Peripheral Neuropathy
T3	AdverseReaction 295 316	Embryo-Fetal Toxicity
T4	AdverseReaction 319 329	Fetal harm
T5	AdverseReaction 404 419	QT Prolongation
T6	AdverseReaction 695 706	neutropenia
T7	Severity 688 694	Severe
T8	AdverseReaction 1036 1047	neutropenia
T9	Severity 1028 1035	Grade 4
T10	AdverseReaction 1052 1071	febrile neutropenia
T11	AdverseReaction 1198 1209	neutropenia
T12	Severity 1190 1197	Grade 4
T13	AdverseReaction 1214 1233	febrile neutropenia
T14	AdverseReaction 1741 1762	peripheral neuropathy
T15	Severity 1733 1740	Grade 3
T16	AdverseReaction 1852 1873	Peripheral neuropathy
T17	AdverseReaction 1967 1977	Neuropathy
T18	AdverseReaction 2112 2122	neuropathy
T19	AdverseReaction 2657 2667	fetal harm
T20	DrugClass 2599 2620	microtubule inhibitor
T21	AdverseReaction 2707 2728	Embryo-fetal toxicity
T22	AdverseReaction 2733 2747	teratogenicity
T23	Animal 2760 2764	rats
T24	AdverseReaction 3179 3194	QT prolongation
T25	AdverseReaction 3265 3280	QT prolongation
T26	Negation 3262 3264	no
T27	Factor 330 333	can
T28	Severity 1804 1811	Grade 4
T29	Factor 2877 2879	If
T30	Factor 3027 3032	fetus
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4 Hypothetical:E27
E5	AdverseReaction:T5
E6	AdverseReaction:T6 Effect:E7
E7	Severity:T7
E8	AdverseReaction:T8 Effect:E9
E9	Severity:T9
E10	AdverseReaction:T10
E11	AdverseReaction:T11 Effect:E12
E12	Severity:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14 Effect:E15
E15	Severity:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19 Hypothetical:E20
E20	DrugClass:T20
E21	AdverseReaction:T21 Hypothetical:E23
E22	AdverseReaction:T22 Hypothetical:E23
E23	Animal:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25 Negated:E26
E26	Negation:T26
E27	Factor:T27
E28	AdverseReaction:T14 Effect:E29
E29	Severity:T28
E30	Factor:T29
E31	Factor:T30
A1	CUI E1 C0027947
A2	UMLS-Preferred-Name E1 Neutropenia
A3	MEDDRA-PT E1 Neutropenia
A4	MEDDRA-PT-ID E1 10029354
A5	CUI E2 C0031117
A6	UMLS-Preferred-Name E2 Peripheral Neuropathy
A7	MEDDRA-PT E2 Neuropathy peripheral
A8	MEDDRA-PT-ID E2 10029331
A9	CUI E3 C0270009
A10	UMLS-Preferred-Name E3 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A11	MEDDRA-PT E3 Maternal drugs affecting foetus
A12	MEDDRA-PT-ID E3 10026923
A13	LLT E3 Drug toxicity NEC affecting foetus
A14	LLT-ID E3 10013750
A15	CUI E4 C0854268
A16	UMLS-Preferred-Name E4 Foetal damage
A17	MEDDRA-PT E4 Foetal damage
A18	MEDDRA-PT-ID E4 10016852
A19	LLT E4 Fetal damage
A20	LLT-ID E4 10054743
A21	CUI E5 C0151878
A22	UMLS-Preferred-Name E5 Prolonged QT interval
A23	MEDDRA-PT E5 Electrocardiogram QT prolonged
A24	MEDDRA-PT-ID E5 10014387
A25	LLT E5 QT prolonged
A26	LLT-ID E5 10037705
A27	CUI E6 C0027947
A28	UMLS-Preferred-Name E6 Neutropenia
A29	MEDDRA-PT E6 Neutropenia
A30	MEDDRA-PT-ID E6 10029354
A31	CUI E8 C0027947
A32	UMLS-Preferred-Name E8 Neutropenia
A33	MEDDRA-PT E8 Neutropenia
A34	MEDDRA-PT-ID E8 10029354
A35	CUI E10 C0746883
A36	UMLS-Preferred-Name E10 Febrile Neutropenia
A37	MEDDRA-PT E10 Febrile neutropenia
A38	MEDDRA-PT-ID E10 10016288
A39	CUI E11 C0027947
A40	UMLS-Preferred-Name E11 Neutropenia
A41	MEDDRA-PT E11 Neutropenia
A42	MEDDRA-PT-ID E11 10029354
A43	CUI E13 C0746883
A44	UMLS-Preferred-Name E13 Febrile Neutropenia
A45	MEDDRA-PT E13 Febrile neutropenia
A46	MEDDRA-PT-ID E13 10016288
A47	CUI E14 C0031117
A48	UMLS-Preferred-Name E14 Peripheral Neuropathy
A49	MEDDRA-PT E14 Neuropathy peripheral
A50	MEDDRA-PT-ID E14 10029331
A51	CUI E16 C0031117
A52	UMLS-Preferred-Name E16 Peripheral Neuropathy
A53	MEDDRA-PT E16 Neuropathy peripheral
A54	MEDDRA-PT-ID E16 10029331
A55	CUI E17 C0442874
A56	UMLS-Preferred-Name E17 Neuropathy
A57	MEDDRA-PT E17 Neuropathy peripheral
A58	MEDDRA-PT-ID E17 10029331
A59	LLT E17 Neuropathy
A60	LLT-ID E17 10029328
A61	CUI E18 C0442874
A62	UMLS-Preferred-Name E18 Neuropathy
A63	MEDDRA-PT E18 Neuropathy peripheral
A64	MEDDRA-PT-ID E18 10029331
A65	LLT E18 Neuropathy
A66	LLT-ID E18 10029328
A67	CUI E19 C0854268
A68	UMLS-Preferred-Name E19 Foetal damage
A69	MEDDRA-PT E19 Foetal damage
A70	MEDDRA-PT-ID E19 10016852
A71	LLT E19 Fetal damage
A72	LLT-ID E19 10054743
A73	CUI E21 C0270009
A74	UMLS-Preferred-Name E21 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A75	MEDDRA-PT E21 Maternal drugs affecting foetus
A76	MEDDRA-PT-ID E21 10026923
A77	LLT E21 Drug toxicity NEC affecting foetus
A78	LLT-ID E21 10013750
A79	CUI E22 C0232910
A80	UMLS-Preferred-Name E22 Teratogenesis
A81	MEDDRA-PT E22 Teratogenicity
A82	MEDDRA-PT-ID E22 10043275
A83	CUI E24 C0151878
A84	UMLS-Preferred-Name E24 Prolonged QT interval
A85	MEDDRA-PT E24 Electrocardiogram QT prolonged
A86	MEDDRA-PT-ID E24 10014387
A87	LLT E24 QT prolonged
A88	LLT-ID E24 10037705
A89	CUI E25 C0151878
A90	UMLS-Preferred-Name E25 Prolonged QT interval
A91	MEDDRA-PT E25 Electrocardiogram QT prolonged
A92	MEDDRA-PT-ID E25 10014387
A93	LLT E25 QT prolonged
A94	LLT-ID E25 10037705
